RU2006132127A - APPLICATION OF NIFUROXASIDE AS A COMPONENT OF COMBINED MEDICINE THERAPY OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI, AND A METHOD OF TREATMENT AIMED AT ERADICATION OF AN ACTIVATOR - Google Patents
APPLICATION OF NIFUROXASIDE AS A COMPONENT OF COMBINED MEDICINE THERAPY OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI, AND A METHOD OF TREATMENT AIMED AT ERADICATION OF AN ACTIVATOR Download PDFInfo
- Publication number
- RU2006132127A RU2006132127A RU2006132127/15A RU2006132127A RU2006132127A RU 2006132127 A RU2006132127 A RU 2006132127A RU 2006132127/15 A RU2006132127/15 A RU 2006132127/15A RU 2006132127 A RU2006132127 A RU 2006132127A RU 2006132127 A RU2006132127 A RU 2006132127A
- Authority
- RU
- Russia
- Prior art keywords
- component
- nifuroxazide
- drug therapy
- pylori
- helicobacter pylori
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/345—Nitrofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Claims (11)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2006132127/15A RU2006132127A (en) | 2006-09-06 | 2006-09-06 | APPLICATION OF NIFUROXASIDE AS A COMPONENT OF COMBINED MEDICINE THERAPY OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI, AND A METHOD OF TREATMENT AIMED AT ERADICATION OF AN ACTIVATOR |
PCT/RU2007/000477 WO2008030141A1 (en) | 2006-09-06 | 2007-09-05 | Use of nifuroxazide in the form of a component of a combined drug therapy for treating diseases associated with helicobacter pylori and a curing method for eradicating a causative agent |
RSP-2009/0150A RS20090150A (en) | 2006-09-06 | 2007-09-05 | Use of nifuroxazide in the form of a component of a combined drug therapy for treating diseases associated with helicobacter pylori and a curing method for eradicating a causative agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2006132127/15A RU2006132127A (en) | 2006-09-06 | 2006-09-06 | APPLICATION OF NIFUROXASIDE AS A COMPONENT OF COMBINED MEDICINE THERAPY OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI, AND A METHOD OF TREATMENT AIMED AT ERADICATION OF AN ACTIVATOR |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2006132127A true RU2006132127A (en) | 2008-03-20 |
Family
ID=39157480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2006132127/15A RU2006132127A (en) | 2006-09-06 | 2006-09-06 | APPLICATION OF NIFUROXASIDE AS A COMPONENT OF COMBINED MEDICINE THERAPY OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI, AND A METHOD OF TREATMENT AIMED AT ERADICATION OF AN ACTIVATOR |
Country Status (3)
Country | Link |
---|---|
RS (1) | RS20090150A (en) |
RU (1) | RU2006132127A (en) |
WO (1) | WO2008030141A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2446797C1 (en) * | 2011-02-24 | 2012-04-10 | Петр Леонидович Щербаков | Method of treating acid-dependent conditions associated with helicobacter pylori |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3313519B1 (en) * | 2015-06-29 | 2023-05-31 | Children's Medical Center Corporation | Jak-stat inhibitors for the treatment of congenital myopathies |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9201930D0 (en) * | 1992-06-24 | 1992-06-24 | Astra Ab | GASTRIC ANTIBACTERIAL TREATMENT |
SE9500422D0 (en) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9700885D0 (en) * | 1997-03-12 | 1997-03-12 | Astra Ab | New pharmaceutical formulation |
-
2006
- 2006-09-06 RU RU2006132127/15A patent/RU2006132127A/en not_active Application Discontinuation
-
2007
- 2007-09-05 RS RSP-2009/0150A patent/RS20090150A/en unknown
- 2007-09-05 WO PCT/RU2007/000477 patent/WO2008030141A1/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2446797C1 (en) * | 2011-02-24 | 2012-04-10 | Петр Леонидович Щербаков | Method of treating acid-dependent conditions associated with helicobacter pylori |
Also Published As
Publication number | Publication date |
---|---|
RS20090150A (en) | 2010-10-31 |
WO2008030141A1 (en) | 2008-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2016164165A5 (en) | ||
EA200870325A1 (en) | MEDICAL FORMS FOR THE INTRODUCTION OF COMBINATIONS OF MEDICINES | |
RU2007132181A (en) | ANTI-CANCER MEDICINE CONTAINING α, α, α-TRIFTORTIMIDINE AND A THIMIDINFOSPHORILYLASE INHIBITOR | |
JP2006501240A5 (en) | ||
WO2009017716A3 (en) | Pulsatile gastric retentive dosage forms | |
JP2020108787A (en) | Intraluminal therapy system for gastrointestinal infections | |
CN109893516A (en) | For treating the pharmaceutical composition of helicobacter pylori | |
WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
EA022204B1 (en) | Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum | |
JP2002525266A5 (en) | ||
WO2007079195A3 (en) | Gastric retentive gabapentin dosage forms and methods for using same | |
WO2006134492A3 (en) | Acarbose methods and formulations for treating chronic constipation | |
Phillips et al. | A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers | |
AU2016277587B2 (en) | Buffered upper GI absorption promoter | |
RU2006132127A (en) | APPLICATION OF NIFUROXASIDE AS A COMPONENT OF COMBINED MEDICINE THERAPY OF DISEASES ASSOCIATED WITH HELICOBACTER PYLORI, AND A METHOD OF TREATMENT AIMED AT ERADICATION OF AN ACTIVATOR | |
RU2004131214A (en) | METHODS FOR TREATING COGNITIVE DISORDERS | |
US20230414652A1 (en) | Composition and therapy for treatment of gag reflexes | |
RU2016144695A (en) | COMPLEX OF SITAGLIPTIN TANNA | |
RU2003133155A (en) | METHOD FOR ERADICATING HELICOBACTER PYLORI INFECTIONS IN THE STOMACH | |
JP2011178722A (en) | PHARMACEUTICAL COMPOSITION TO ELIMINATE HELICOBACTER PYLORI (H.pylori) AND METHOD FOR PRODUCING THE SAME | |
Sundaravel et al. | Methylene blue to the rescue in accidental treprostinil overdose | |
RU2004134082A (en) | ANTI-GRIPPOINT MEANS | |
US20130071473A1 (en) | Composition and method for treating ulcers | |
CN104906577B (en) | A kind of pharmaceutical composition for eradicating helicobacter pylori and preparation method thereof | |
US8323702B2 (en) | Composition and method for treating ulcers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20091211 |